20 May 2013
Keywords: connaught, merck, frosst, vaccine, deal, canada, agreed
Article | 13 December 1993
Connaught and Merck Frosst Canada have agreed that Connaught will
manufacture Merck Frosst's hepatitis A vaccine, VAQTA, for the world
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
13 December 1993
© 2013 thepharmaletter.com